HAL (France)
open access
Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 CFR Part 226 — Current Good Manufacturing Practice for Type a Medicated Articles#506805
- A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.#200216
- 21 CFR Part 212 — Current Good Manufacturing Practice for Positron Emission Tomography Drugs#506801
- Data Management and Sharing Plan for: Mechanistic connection between HPV-specific TCRs and therapeutic responses to ICI in HPV+ HNSCC#207849
- Importance Of Ipr In Biotechnology#1181286
Record · ID 347675
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive